FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children

The Food and Drug Administration (FDA) is restricting the use of codeine and tramadol medicines in children. Codeine is approved to treat pain and cough, and tramadol is approved to treat pain. These medicines carry serious risks, including slowed or difficult breathing and death, which appear to be a greater risk in children younger than 12 years, and should not be used in these children. These medicines should also be limited in some older children. Single-ingredient codeine and all tramadol-containing products are FDA-approved only for use in adults. The FDA is also recommending against the use of codeine and tramadol medicines in breastfeeding mothers due to possible harm to their infants. As a result, the FDA is requiring several changes to the labels of all prescription medicines containing these drugs. These new actions further limit the use of these medicines beyond the 2013 restriction of codeine use in children younger than 18 years to treat pain after surgery to remove the tonsils and/or adenoids. The FDA is now adding: FDA’s strongest warning, called a Contraindication , to the drug labels of codeine and tramadol alerting that codeine should not be used to treat pain or cough and tramadol …

You can listen to FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children online on Radio and Podcast. Open the player on this page to stream the available audio.

FDA Restricts Use of Prescription Codeine and Tramadol Pain Medicines in Children is an episode from FDA Drug Information Updates by ReachMD.

This episode is 00:03:00 long.

This episode was published on Apr 20, 2017.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.